Records containing: IgA Nephropathy (IgAN)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases
-
CLINICAL_TRIALS study record update · 2026-04-22A Phase 2 Study to Assess ADX-038 in Participants With Complement-Mediated Kidney Disease
-
CLINICAL_TRIALS study record update · 2026-04-16A Clinical Study on the Safety and Efficacy of CD19-Targeted Universal CAR-γδ T Cells in Relapsed/Refractory Autoimmune Nephropathy
-
CLINICAL_TRIALS study record update · 2026-04-13A Study Evaluating Monthly (Every 4 Weeks) Dosing of Atacicept in Patients With IgAN
-
CLINICAL_TRIALS study record update · 2026-04-02An Exploratory Clinical Study Evaluate the Safety and Efficacy of Universal Universal Allogeneic CAR-T Cells Targeting CD19 and BCMA in the Treatment of B Cell-Related Autoimmune Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-03A Phase I Clinical Study to Evaluate the Safety, Tolerability, PK and PD of RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment
-
CLINICAL_TRIALS study record update · 2026-02-05A Randomized, Double-blind, and Placebo-controlled Parallel Phase Ⅲ Clinical Study to Evaluate the Efficacy and Safety of HSK39297 Tablets in Treatment of Patients With Primary IgAN
-
CLINICAL_TRIALS study record update · 2026-02-03A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
-
CLINICAL_TRIALS study record update · 2026-01-22The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2026-01-15A Multicenter Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2025-12-26A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic/Pharmacodynamic Characteristics of RG002C0106 Injection in Subjects With Primary IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2025-10-03A Multi-Center, Phase II, Open Label, Randomized Trial Evaluating the Efficacy and Safety of Complement 5a Receptor Antagonist Avacopan in Crescentic IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2025-08-01To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy, Single Center, Randomized, Open Label, Comparative Study
-
CLINICAL_TRIALS study record update · 2025-07-22RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)
-
CLINICAL_TRIALS study record update · 2025-07-10Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis
-
CLINICAL_TRIALS study record update · 2025-07-09Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial
-
CLINICAL_TRIALS study record update · 2025-07-04An Exploratory Clinical Study of the Safety and Efficacy of Anti-CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in the Treatment of IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2025-06-15Evaluating the Impact of Autoimmune Protocol Diet on Proteinuria in Patients With IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2025-04-08A Multicenter, Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept
-
CLINICAL_TRIALS study record update · 2025-02-17A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of SC0062 Capsule in Patients with IgA Nephropathy and Proteinuria (SUCCESS-1)
-
CLINICAL_TRIALS study record update · 2025-01-22A Phase 2, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of SGB-9768 in Patients with Primary IgA Nephropathy, C3 Glomerulopathy, and Immune Complex-mediated Membranoproliferative Glomerulonephritis.
-
CLINICAL_TRIALS study record update · 2025-01-07Research on Raman Spectroscopy Detection Technology in Kidney Disease Diagnosis
-
CLINICAL_TRIALS study record update · 2025-01-01A Multicenter, Randomized, Controlled Clinical Study on the Efficacy and Safety of Telitacicept in Patients with IgA Nephropathy
-
CLINICAL_TRIALS study record update · 2024-11-18A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)
-
CLINICAL_TRIALS study record update · 2024-11-01A Randomized, Double-blind, and Placebo-controlled Parallel Phase II Clinical Study to Evaluate the Efficacy and Safety of HSK39297 Tablets in Treatment of Patients with Primary IgAN